(48 days)
Not Found
No
The document explicitly states "Mentions AI, DNN, or ML: Not Found". The description focuses on standard ultrasound imaging modes and measurement packages, with no indication of AI/ML capabilities.
No
The "Intended Use / Indications for Use" section explicitly states that the device is for "clinical diagnosis purposes" and provides "information to the clinician that may be used adjunctively with other medical data... for clinical diagnosis purposes." It is described as a "diagnostic ultrasound system," indicating its role in identifying medical conditions rather than treating them.
Yes
Explanation: The "Device Description" explicitly states that the ultrasound systems are "diagnostic ultrasound systems." Additionally, the "Intended Use / Indications for Use" section mentions that the system's calculation packages "provide information to the clinician that may be used adjunctively with other medical data obtained by a physician for clinical diagnosis purposes."
No
The device description explicitly states it is a "software controlled diagnostic ultrasound system" and describes hardware components like transducers (implied by ultrasound echo data acquisition) and a Flat Panel Display. It also mentions an "Acuson Acunav Ultrasound Catheter," which is a hardware component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices intended for use in vitro for the examination of specimens, including blood, tissue, and urine, derived from the human body, solely or principally for the purpose of providing information concerning a physiological or pathological state, or concerning a congenital abnormality, or to determine the safety and compatibility of transfused blood, or to monitor therapeutic measures.
- Device Function: The description clearly states that this is an ultrasound imaging system. Ultrasound is a non-invasive imaging modality that uses sound waves to create images of internal body structures. It does not involve the examination of specimens in vitro.
- Intended Use: The intended uses listed are all related to imaging and visualization of anatomical structures within the body. While the system provides measurements and calculations that can be used adjunctively with other medical data for clinical diagnosis, the primary function is imaging, not the analysis of biological specimens outside the body.
- Arterial Health Package (AHP): Even the AHP, which measures Intima Media Thickness, does so through ultrasound imaging of the carotid artery in vivo, not by analyzing a blood sample or other specimen in vitro.
Therefore, the device's function and intended use fall under the category of medical imaging devices, not In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
The ultrasound imaging systems are intended for the following applications: Fetal, Abdominal, Intraoperative, Pediatric, Small Parts, Transcranial, OB/GYN, Cardiac, Pelvic, Neonatal/Adult Cephalic, Vascular, Musculoskeletal, Superficial Musculoskeletal, and Peripheral Vascular applications.
The system also provides the ability to measure anatomical structures (fetal, abdominal, intraoperative, pediatric, small organ, neonatal cephalic, cardiac, trans-esophageal, transrectal, transvaginal, peripheral vessel, musculo-skeletal (conventional), musculo-skeletal (superficial) and calculation packages that provide information to the clinician that may be used adjunctively with other medical data obtained by a physician for clinical diagnosis purposes.
The Arterial Health Package (AHP) software provides the physician with the capability to measure Intima Media Thickness and the option to reference normative tables that have been validated and gublished in peer-reviewed studies. The information is intended to provide the physician with an easily understood tool for communicating with palients regarding state of their cardiovascular system. This feature should be utilized according to the "ASE Consensus Statement; Use of Carolid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Association of Echocardionraphy: Carotid Intima-Media Thickness Task Force, Endorsed by the Society for Vascular Imaging".
The Acuson Acunav Ultrasound Catheter is intra-cardiac and intra-luminal visualization of cardiac and great vessel anatomy and physiology, as well as visualization of other devices in the heart of adult and pediatric patients.
Product codes (comma separated list FDA assigned to the subject device)
90-IYN, 90-IYC, 90-ITX, OBJ
Device Description
The ultrasound systems are multi-purpose mobile, software controlled diagnostic ultrasound systems with and onscreen display for thermal and mechanical indices related to potential bio-effect mechanisms. The function is to acquire primary or secondary harmonic ultrasound echo data and display it in B-Mode, M-Mode, Pulsed (PW) Doppler Mode, Continuous (CW) Doppler Mode, Color Doppler Mode, Amplitude Doppler Mode, a combination of modes, or Harmonic Imaging and 3D/4D Imaging on a Flat Panel Display.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
Fetal, Abdominal, Intraoperative, Pediatric, Small Parts, Transcranial, OB/GYN, Cardiac, Pelvic, Neonatal/Adult Cephalic, Vascular, Musculoskeletal, Superficial Musculoskeletal, Peripheral Vascular, Adult, Intra-cardiac, Intra-luminal visualization of cardiac and great vessel anatomy and physiology
Indicated Patient Age Range
Adult and Pediatric
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K130619, K123622, K123001, K130739, K112596, K121138
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
K132804
page 1 of 5
S-Family Ultrasound Systems 510(k) Submission
510(k) Summary Prepared July 18, 2013
| 1. Sponsor: | Siemens Medical Solutions, Inc.,
Ultrasound Division
685 East Middlefield Road
Mountain View, California 94043 | | OCT 2 4 2013 |
|-----------------|-------------------------------------------------------------------------------------------------------------------------|----------------------------------|--------------|
| Contact Person: | Christine Dunn
Telephone:
Fax: | (425) 785-1617
(425) 391-9161 | |
| 2. Device Name: | Acuson S1000, S2000, S3000™ Diagnostic Ultrasound Systems. | | |
| Common Name: | Diagnostic Ultrasound System | | |
| Classification: | | | |
Regulatory Class: ll Review Category: Tier II Classification Panel: Radiology
Ultrasonic Pulsed Doppler Imaging System | FR # 892.1550 | Product Code 90-IYN |
---|---|---|
Ultrasonic Pulsed Echo Imaging System | FR # 892.1560 | Product Code 90-IYC |
Diagnostic Ultrasound Transducer | FR # 892.1570 | Product Code 90-ITX |
Diagnostic Ultrasound Catheter | FR # 870.1200 | Product Code OBJ |
3. Legally Marketed Predicate Devices
The modified Acuson S1000, S2000, S3000 Ultrasound Systems are substantially equivalent to the company's own systems:
System | 510(k) |
---|---|
S1000 | K130619; K123622; K123001 |
S2000 | K130739; K112596; K123622; K123001 |
S3000 | K130739; K121138; K123622; K123001 |
4. Device Description:
The ultrasound systems are multi-purpose mobile, software controlled diagnostic ultrasound systems with and onscreen display for thermal and mechanical indices related to potential bio-effect mechanisms. The function is to acquire primary or secondary harmonic ultrasound echo data and display it in B-Mode, M-Mode, Pulsed (PW) Doppler Mode, Continuous (CW) Doppler Mode, Color Doppler Mode, Amplitude Doppler Mode, a combination of modes, or Harmonic Imaging and 3D/4D Imaging on a Flat Panel Display.
5. Intended Use
The ultrasound imaging systems are intended for the following applications: Fetal, Abdominal, Intraoperative, Pediatric, Small Parts, Transcranial, OB/GYN, Cardiac, Pelvic, Neonatal/Adult Cephalic, Vascular, Musculoskeletal, Superficial Musculoskeletal, and Peripheral Vascular applications.
1
Siemens Medical Solutions, Inc. | S-Family Ultrasound Systems |
---|---|
Ultrasound Division | 510(k) Submission |
The system also provides the ability to measure anatomical structures {fetal, abdominal, intraoperative, pediatric, small organ, neonatal cephalic, cardiac, cardiac, trans-esophageal, transvaginal, peripheral vessel, musculo-skeletal (conventional), musculo-skeletal (superficial) and neonatal cardiac) and calculation packages that provide information to the clinician that may be used adjunctively with other medical data obtained by a physician for clinical diagnosis purposes.
The Arterial Health Package (AHP) software provides the physician with the capability to measure Intima Media Thickness and the option to reference normalive tables that have been validated and published in peer-reviewed studies. The information is intended to provide the physician with an easily understood tool for communicating with patients regarding state of their cardiovascular system. This feature should be utilized according to the "ASE Consensus Statement: Use of Carolid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Association of Echocardionraphy: Carotid Intima-Media Thickness Task Force, Endorsed by the Society for Vascular Imaging".
The Acuson Acunav Ultrasound Catheter is intra-cardiac and intra-luminal visualization of cardiac and great vessel anatomy and physiology, as well as visualization of other devices in the heart of adult and pediatric patients.
1986年 1986 - 1987 - 1987 - 1987 - 1987 - 1987 - 1998 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991
| | Feature / Characteristic | Acuson
S1000/S2000
/S3000
This
Submission | Acuson
SC2000
K123622 | Acuson
S1000
K130619 | Acuson
S2000
K112596 | Acuson
S2000
K130739 | Acuson
S3000
K121138 | Acuson
S3000
K130739 |
|---------------------------------------------------|-------------------------------------------------------|-------------------------------------------------------|-----------------------------|----------------------------|----------------------------|----------------------------|----------------------------|----------------------------|
| | Indications for Use: | | | | | | | |
| | Fetal | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | Abdominal | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | Intraoperative | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | Intraoperative neurological | - | - | - | - | - | - | - |
| | Pediatric | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | Small Organ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | Neonatal cephalic | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | Adult Cephalic | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | Cardiac | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | Trans-esophageal | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | Transrectal | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | Transvaginal | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | Peripheral vessel | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | Laparoscopic | - | - | - | - | - | - | - |
| | Musculo-skeletal (conventional) | ✓ | - | - | - | - | - | - |
| ■ | Musculo-skeletal (superficial) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | - |
| | Center Frequencies Supported: | | | | | | | |
| | 2.0 MHz | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | 3.0 MHz | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | 3.2 MHz | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | 3.3 MHz | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | 4.2 MHz | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| | 4.4 MHz | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Feature / Characteristic | Acuson
S1000/S2000
/S3000
This
Submission | Acuson
SC2000
K123622 | Acuson
S1000
K130619 | Acuson
S2000
K112596 | Acuson
S2000
K130739 | Acuson
S3000
K121138 | Acuson
S3000
K130739 | |
| 4.8 MHz | √ | √ | √ | √ | √ | √ | √ | |
| •
5.0 MHz | √ | √ | √ | √ | √ | √ | √ | |
| 5.2 MHz | √ | √ | √ | √ | √ | √ | √ | |
| •
6.0 MHz | √ | √ | √ | √ | √ | √ | √ | |
| •
6.5 MHz | √ | √ | √ | √ | √ | √ | √ | |
| •
6.9 MHz | √ | √ | √ | √ | √ | √ | √ | |
| •
9.5 MHz | √ | √ | √ | √ | √ | √ | √ | |
| 10.0 MHz | √ | √ | √ | √ | √ | √ | √ | |
| Modes: | | | | | | | | |
| •
B | √ | √ | √ | √ | √ | √ | √ | |
| •
Parallel processing in B mode | √ | √ | √ | √ | √ | √ | √ | |
| •
M | √ | √ | √ | √ | √ | √ | √ | |
| •
PWD (Pulsed Wave Doppler) | √ | √ | √ | √ | √ | √ | √ | |
| •
CWD (Continuous Wave Doppler) | √ | √ | √ | √ | √ | √ | √ | |
| •
D (Color Doppler) | √ | √ | √ | √ | √ | √ | √ | |
| •
Amplitude Doppler | √ | √ | √ | √ | √ | √ | √ | |
| •
Combined (BMDC)
Features: | √ | √ | √ | √ | √ | √ | √ | |
| Quad processing in color | √ | √ | √ | √ | √ | √ | √ | |
| •
Native™ tissue harmonic imaging | √ | √ | √ | √ | √ | √ | √ | |
| •
SieScape™ panoramic imaging | √ | √ | √ | √ | √ | √ | √ | |
| •
Color SieScape™ panoramic
imaging | √ | √ | √ | √ | √ | √ | √ | |
| • 3-Scape™ real-time 3D imaging | √ | √ | √ | √ | √ | √ | √ | |
| • fourSight™ 4D transducer
technology | √ | √ | √ | √ | √ | √ | √ | |
| • TEQ™ ultrasound technology | √ | √ | √ | √ | √ | √ | √ | |
| Cardiac Imaging
physiological signal display | √ | √ | √ | √ | √ | √ | √ | |
| syngo ® Auto OB measurements | √ | √ | √ | √ | √ | √ | √ | |
| •
Advanced SieClear™ spatial
compounding | √ | √ | √ | √ | √ | √ | √ | |
| STIC (Fetal Heart Imaging) | √ | √ | √ | √ | √ | √ | √ | |
| •
Amnioscopic rendering | √ | √ | √ | √ | √ | √ | √ | |
| •
Cadence contrast agent imaging | √ | √ | √ | √ | √ | √ | √ | |
| •
Clarify ™ vascular enhancement
technology | √ | √ | √ | √ | √ | √ | √ | |
| •
eSie™ Touch elasticity imaging | √ | √ | √ | √ | √ | √ | √ | |
| •
syngo ® Auto Left heart | √ | √ | √ | √ | √ | √ | √ | |
| •
syngo ® Velocity Vector Imaging | √ | √ | √ | √ | √ | √ | √ | |
| Semi Auto-segmentation (eSie
Calc) | √ | √ | √ | √ | √ | √ | √ | |
| Custom Tissue Imaging / Speed of
Sound | √ | √ | √ | √ | √ | √ | √ | |
| •
AHP | √ | √ | √ | √ | √ | √ | √ | |
| Feature / Characteristic | Acuson
S1000/S2000
/S3000
This
Submission | Acuson
SC2000
K123622 | Acuson
S1000
K130619 | Acuson
S2000
K112596 | Acuson
S2000
K130739 | Acuson
S3000
K121138 | Acuson
S3000
K130739 | |
| • VTI (S2000 & S3000 only) | √ | | | | √ | | √ | |
| Wireless | √ | √ | √ | | | | | |
| Monitor: 21' FPD | √ | √ | √ | √ | √ | √ | √ | |
| Output Display Standard (Track 3) | √ | √ | √ | √ | √ | √ | √ | |
| Patient Contact Materials | Tested to ISO
10993-1 | Tested to
ISO 10993-1 | Tested to
ISO 10993-1 | Tested to ISO
10993-1 | Tested to ISO
10993-1 | Tested to ISO
10993-1 | Tested to ISO
10993-1 | |
| UL 60601-1 Certified | √ | √ | √ | √ | √ | √ | √ | |
| Indications for Use | √ | √ | √ | √ | √ | √ | √ | |
6. Summary of Technological Characteristics - New Device Compared to Predicate
2
S-Family Ultrasound Systems 510(k) Submission
S-Family 510(k) Submission
Page 10 of 64
3
S-Family Ultrasound Systems 510(k) Submission
7. A brief discussion of nonclinical tests submitted, referenced, or relied on in the 510(k) for a determination of substantial equivalence.
The device has been evaluated for acoustic output, biocompatibility, cleaning and disinfection effectiveness as well as thermal, electrical, electromagnetic and has been found to conform with applicable medical device safety standards. The system complies with the following voluntary standards;
- UL 60601-1, Safety Requirements for Medical Equipment .
- IEC 60601-2-37 Diagnostic Ultrasound Safety Standards .
- CSA C22.2 No. 601-1, Safety Requirements for Medical Equipment 이
- 트 AIUM/NEMA UD-3, Standard for Real Time Display of Thermal and Mechanical Acoustic Output Indices on Diagnostic Ultrasound Equipment
- AIUM/NEMA UD-2, Acoustic Output Measurement Standard for Diagnostic Ultrasound ■
- 93/42/EEC Medical Devices Directive l
- Safety and EMC Requirements for Medical Equipment I
- EN/IEC 60601-1 .
- EN/IEC 60601-1-1 .
- . EN/IEC 60601-1-2
- IEC 1157 Declaration of Acoustic Power .
- ISO 10993-1 Biocompatibility .
Cleared patient contact materials, electrical and mechanical safety are unchanged.
Additional testing was performed to verify the software release as well as transducer and wireless performance.
- A summary discussion of the clinical tests submitted, referenced, or relied on for a determination of substantial equivalence.
Since the S1000, S2000, S3000 systems use the same technology and principles as existing devices, clinical data is not required.
9. Summary
Intended uses and other key features are consistent with traditional clinical practice and FDA guidelines. The design and development process of the manufacturer conforms with 21 CFR 820 Quality System Regulation and ISO 13485:2003 quality system standards. The product is designed to conform to applicable medical device safety standards and compliance is verified through independent evaluation with ongoing factory surveillance. Diagnostic ultrasound has
accumulated a long history of safe and effective performance. Therefore it is the opinion
4
K132804
Page 5 of 5
S-Family Ultrasound Systems 510(k) Submission
of Siemens Medical that the S1000, S2000 and S3000 systems are substantially equivalent with respect to safety and effectiveness to devices currently cleared for market. .
S-Family 510(k) Submission
.
·
Page 12 of 64
5
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/5/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features the department's seal, which includes an emblem of an eagle with three bars on its wing. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the emblem.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
October 24, 2013
Siemens Medical Solutions USA, Inc. % Mr. Mark Job Responsible Third Party Official Regulatory Technology Services LLC 1394 25th Street NW BUFFALO MN 55313
Re: K132804
Trade/Device Name: Acuson S1000/ S2000/ S3000" Diagnostic Ultrasound Systems Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: 1YN. IYO. ITX and OBJ Dated: October 9, 2013 Received: October 10, 2013
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading,
This determination of substantial equivalence applies to the following transducers intended for use with the Acuson S1000/S3000 Diagnostic Ultrasound System, as described in your premarket notification:
Transducer Model Number | ||
---|---|---|
CW2 | CWS | EC9-4 |
MC9-4 | 91_4 | 141.5 |
4 | 6C2 | 4CI |
RCIFID | 8C3HD | 4V |
10V4 | 141.5 SP | 7CF2 |
7CF1 | 9EVF4 | V SMs |
18L6 | 8V3 | 4V lc |
613 | EV8C4 | V7M TEE |
AcuNav 8F | AcuNav 10F |
6
Page 2-Mr. Job
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the clectronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.lda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.lda.gov/MedicalDevices/Safetv/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours.
Smhif)
for
Janine M. Morris Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
7
1.3 Indications for Use
K132804 A. 510(k) Number (if known):
Device Name: S1000, S2000, S3000 Diagnostic Ultrasound Systems
Indications for Use:
The ultrasound imaging systems are intended for the following applications: Fetal, Abdominal, Intraoperative, Pediatric, Small Parts, Transcranial, OB/GYN, Cardiac, Pelvic, Neonatal/Adult Cephalic, Vascular, Musculoskeletal, Superficial Musculoskeletal, and Peripheral Vascular applications.
The system also provides the ability to measure anatomical structures (fetal, abdominal, intraoperative, pediatric, small organ, neonatal cephalic, cardiac, trans-esophageal, transrectal, transvaginal, peripheral vessel, musculo-skeletal (conventional), musculo-skeletal (superficial) and calculation packages that provide information to the clinician that may be used adjunctively with other medical data obtained by a physician for clinical diagnosis purposes.
The Arterial Health Package (AHP) software provides the physician with the capability to measure Intima Media Thickness and the option to reference normative tables that have been validated and gublished in peer-reviewed studies. The information is intended to provide the physician with an easily understood tool for communicating with palients regarding state of their cardiovascular system. This feature should be utilized according to the "ASE Consensus Statement; Use of Carolid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Association of Echocardionraphy: Carotid Intima-Media Thickness Task Force, Endorsed by the Society for Vascular Imaging".
The Acuson Acunav Ultrasound Catheter is intra-cardiac and intra-luminal visualization of cardiac and great vessel anatomy and physiology, as well as visualization of other devices in the heart of adult and pediatric patients.
Prescription Use × (Part 21CFR 801 Subpart D) Over-The-Counter Use _ (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
AND/OR
(min. 77)
.
Division Sign-Off Division of Radiological Health; Office of In Vitro Diagnostics and Radiological Health
K132804 510(k)
Page 1 of ____________________________________________________________________________________________________________________________________________________________________
S-Family 510(k) Submission
Page 16 of 64
8
1.3 Indications for Use Forms
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
Device Name: Intended Use:
ACUSON S1000, S2000, S3000 Ultrasound System Ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | |||||
Doppler | Amplitude | ||||||||||
Doppler | Color | ||||||||||
Velocity | |||||||||||
Imaging | Combined | ||||||||||
(Specify) | Other | ||||||||||
(Specify) | |||||||||||
Ophthalmic | P | P | P | P | P | P | |||||
Fetal | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | |||
11, 13 | |||||||||||
Abdominal | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | |||
11, 13, 16, 18 | |||||||||||
Intraoperative | |||||||||||
(Note 9) | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | |||
11, 14 | |||||||||||
Intraoperative | |||||||||||
Neurological | P | P | P | P | P | P | Note 2,3,4,5,7,8,10, | ||||
11 | |||||||||||
Pediatric | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | |||
11 | |||||||||||
Small Organ | |||||||||||
(Note 1) | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | |||
11.14. 16, 18 | |||||||||||
Neonatal Cephalic | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10 | |||
Adult Cephalic | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10 | |||
Cardiac | P | P | P | P | P | P | BMDC | Note | |||
2,3,4,5,6,7,8,10,15 | |||||||||||
Trans-esophageal | P | P | P | P | P | P | BMDC | Note 4 | |||
Transrectal | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | |||
11.14 | |||||||||||
Transvaginal | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | |||
11 | |||||||||||
Transurethral | |||||||||||
Intravascular | |||||||||||
Peripheral vessel | P | P | P | P | P | P | BMDC | Note 2,3,4,5,6,7,8,10, | |||
11,14,15 | |||||||||||
Laparoscopic | |||||||||||
Musculo-skeletal | |||||||||||
Conventional | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | |||
11.14, 18 | |||||||||||
Musculo-skeletal | |||||||||||
Superficial | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | |||
11,14, 18 | |||||||||||
Other (specify) | P | P | P | P | P | P | BMDC | Note 3,4,6, 10 |
N = new natalian, P = previously classed by FDA K032142, K03034, K09302, K111674, K112556, K12113, K123001, K120615, K12136 K12302, K12053
Nole 1 e breast, testes thyroid penis, prostate etc
Nole 7
Clarity VE vascular ennancoment technology
eSæ ™ Touch elasticity imaging / FTI Nole 10
Nole 14
Note 17 e Sie Fusion
Note 18 VTI
A
Note 2 Ensamble tissue harmonic imaging Note 5 3-Scape real-time 3D imaging Note 8 Power SieScape panoramic imaging Note 11 Advanced Sieclear spatial compounding Note 15 AHP
Note 3 SieClear mulli-view spatial compounding Note 6 Cadence contrast agent imaging Note 9 For example vascular, abdominal Note 13 STIC
Note 16 Custom Tissue Imaging
(PLEASE DO NOT WRITE BELOW THIS LINE.CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH. Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off
Division of Radiological Health; Office of In Vitro Diagnostics and Radiological Health 510(k)_
Page 2 of ____________________________________________________________________________________________________________________________________________________________________
S-Family 510(k) Submission
Page 17 of 64
Tissue Equa ization Technology
B&W SieScape panoramic imaging Note 4
9
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (il known):
Device Name: Intended Use:
CW2 Probe For Use On ACUSON S1000, S2000, S3000 Ultrasound System Ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | ||||
Doppler | Amplitude | |||||||||
Doppler | Color | |||||||||
Velocity | ||||||||||
Imaging | Combined | |||||||||
(Specify) | Other | |||||||||
(Specify) | ||||||||||
Ophthalmic | ||||||||||
Fetal | P | |||||||||
Abdominal | P | |||||||||
Intraoperative | ||||||||||
(Note 9) | P | |||||||||
Intraoperative | ||||||||||
Neurological | ||||||||||
Pediatric | P | |||||||||
Small Organ | ||||||||||
(Note 1) | P | |||||||||
Neonatal Cephalic | P | |||||||||
Adult Cephalic | P | |||||||||
Cardiac | P | |||||||||
Trans-esophageal | ||||||||||
Transrectal | ||||||||||
Transvaginal | ||||||||||
Transurethral | ||||||||||
Intravascular | ||||||||||
Peripheral vessel | P | |||||||||
Laparoscopic | ||||||||||
Musculo-skeletal | ||||||||||
Conventional | P | |||||||||
Musculo-skeletal | ||||||||||
Superficial | P | |||||||||
Other (specify) |
N = new indication; P = previously cleared by FDA K# 063803, K072786, K090334, , K093812, K111674, K121138
Additional Comments:
Note 1 For example, breast, testes, thyroid, penis, prostate, etc.
Note 9 For example: vascular, abdominal
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Dragnostics and Radiological Health (OIR)
Division Sign-Off
Division of Radiological Health; Office of In Vitro Diagnostics and Radiological Health 510(k)_
Page 3 of _
S-Family 510(k) Submission
Page 18 of 64
10
S-Family Ultrasound Systems 510(k) Submission
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
Device Name: Intended Use:
CW5 Probe For Use On ACUSON S1000, S2000, S3000 Ultrasound System Ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation Color Color Amplitude Combined Other PWD CWD Clinical Application A B M Velocity Doppler Doppler (Specify) (Specify) Imaging Oph:halmic P Fetal P Abdomina! Intraoperative P (Note 9) Intraoperative P Neurological P Pediatric Small Organ P (Note 1) P Neonatal Cephalic Adult Cephalic P P Cardiac Trans-esophageal Transrectal Transvaginal Transurethral Intravascular P Peripheral vessel Laparoscopic Musculo-skeletal P Conventional Musculo-skeletal P Superficial Other (specify)
N = new indication; P = previously cleared by FDA K# 063803, K072786, K081148, K090334 , K093812, K111674, K121138
Additional Comments:
Note 1 For example: breast, testes, thyroid, penis, prostate, etc.
Note 9 For example vascular, abdominat
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OlR)
Division Sign-Off
Division of Radiological Health; Office of In Vitro Diagnostics and Radiological Health 510(k)
Page 4 of _
S-Family 510(k) Submission
Page 19 of 64
11
510 (k) Number (if known):
Device Name:
EC9-4 Curved Array Transducer For Use On ACUSON S1000, S2000, S3000 Ultrasound Systom
Intended Use:
Ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | |||||
Doppler | Amplitude | ||||||||||
Doppler | Color | ||||||||||
Velocity | |||||||||||
Imaging | Combined | ||||||||||
(Specify) | Other | ||||||||||
(Specify) | |||||||||||
Ophthalmic | |||||||||||
Fetal | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, 11 | ||||
Abdominal | P | P | P | P | P | BMDC | Note 2,3,4,5,6,7,8,10, 11, | ||||
Intraoperative | |||||||||||
Intraoperative | |||||||||||
Neurological | |||||||||||
Pediatric | |||||||||||
Small Organ | |||||||||||
(Note 1) | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, 11,14 | ||||
Neonatal Cepnalic | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10,11 | ||||
Adult Cephalic | |||||||||||
Cardiac | |||||||||||
Trans-esophageal | |||||||||||
Transrectal | P | P | P | P | P | BMDC | Note 2,3,4,5, 6, 7,8,10, | ||||
11,14 | |||||||||||
Transvaginal | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10,11 | ||||
Transurethral | |||||||||||
Intravascular | |||||||||||
Peripheral vessel | |||||||||||
Laparoscopic | |||||||||||
Musculo-skeletal | |||||||||||
Conventional | |||||||||||
Musculo-skeletal | |||||||||||
Superficial | |||||||||||
Other (specify) |
N = new indication; P = previously cleared by FDA K# 063803, K072786, K090334, K093812, K111674, K121138
Additional Comments:
For example: breast, testes, thyroid, penis, prostate, etc. Note 1
Ensemble tissue harmonic imaging Note 2
Nole 3 SieClear multi-view spatial compounding
Tissue Equalization Technology Note 4
Note 5 3-Scape real-time 3D imaging
Note 6 Cadence contrast agent imaging
Note 7 B&W SieScape panoramic imaging
Note B Power SieScape panoramic imaging
Note 10 Clarify VE vascular enhancement technology
Advanced Sieclear spatial compounding Note 11
Note 14 eSie™ Touch elasticity imaging / FTI
(PLEASE DO NOT WRITE BELOW THIS LINE.CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Dragnosucs and Radiological Health (OIR)
Division Sign-Off
Division of Radiological Health; Office of In Vitro Diagnostics and Radiological Health
510(k)_
Page 5 of ____________________________________________________________________________________________________________________________________________________________________
S-Family 510(k) Submission
Page 20 of 64
12
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
Device Name:
MC9-4 Curved Array Transducer For Uso On ACUSON S1000, S2000, S3000 Ultrasound Systems
Intended Use:
Ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | ||||
Doppler | Amplitude | |||||||||
Doppler | Color | |||||||||
Velocity | ||||||||||
Imaging | Combined | |||||||||
(Specify) | Other | |||||||||
(Specify) | ||||||||||
Ophthalmic | ||||||||||
Fetal | N | N | N | N | N | BMDC | Note 2,3,4,5,7,8,10, 11 | |||
Abdominal | N | N | N | N | N | BMDC | Note 2,3,4,5,6,7,8,10, 11 | |||
Intraoperative | ||||||||||
Note 9 | ||||||||||
Intraoperative | ||||||||||
Neurological | ||||||||||
Pediatric | ||||||||||
Small Organ | ||||||||||
(Note 1) | N | N | N | N | N | BMDC | Note 2,3,4,5,7,8,10, 11,14 | |||
Neonatal Cephalic | N | N | N | N | N | BMDC | Note 2,3,4,5,7,8,10 | |||
Adult Cephalic | ||||||||||
Cardiac | ||||||||||
Trans-esophageal | ||||||||||
Transrectal | N | N | N | N | N | BMDC | Note 2,3,4,5, 6, 7,8,10, | |||
11,14 | ||||||||||
Transvaginal | N | N | N | N | N | BMDC | Note 2,3,4,5,7,8,10, 11 | |||
Transurethral | ||||||||||
Intravascular | ||||||||||
Peripheral vessel | ||||||||||
Laparoscopic | ||||||||||
Musculo-skeletal | ||||||||||
Conventional | ||||||||||
Musculo-skeletal | ||||||||||
Superficial | ||||||||||
Other (specify) |
N = new indication; P = previously cleared by FDA K# 063803, K072786, K09034, K093812, K111674, K121138, K123001
Additional Comments:
Note 1 For example: breast, testes, thyroid, penis, prostate, etc.
Ensemble tissue harmonic imaging Note 2
Note 3 SieClear multi-view spatial compounding
Note 4 Tissue Equalization Technology
Note 3-Scape real-time 3D imaging
Note 6 Cadence contrast agent imaging
B&W SieScape panoramic imaging Note 7
Power SieScape panoramic imaging Note B
Note 9 Abdomen and Vascular
Note 10 Clarify VE vascular enhancement technology
Note 11 Advanced Sieclear spatial compounding
Note 14 eSie 14 Touch elasticity imaging / FT1
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Health; Office of In Vitro Diagnosucs and Radiological Health 510(k)________________________________________________________________________________________________________________________________________________________________________
510(k) =======================================================================================================================================================================
S-Family 510(k) Submission
Page 21 of 64
Page 6 of
13
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
For Use On ACUSON S1000, S2000, S3000
Device Name:
9L4 Linear Array Transducer For Use On ACUSON S1000, S2000, S30 | ||||
---|---|---|---|---|
Ultrasound Systems |
Intended Use: | Ultrasound imaging or fluid flow analysis of the human body as follows: | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mode of Operation | |||||||||||||
Clinical Application | A | B | M | PWD | CWD | Color | |||||||
Doppler | Amplitude | ||||||||||||
Doppler | Color | ||||||||||||
Velocity | |||||||||||||
Imaging | Combined | ||||||||||||
(Specify) | Other | ||||||||||||
(Specify) | |||||||||||||
Ophthalmic | |||||||||||||
Fetal | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, 11 | ||||||
Abdominal | |||||||||||||
Intraoperative | |||||||||||||
Note 9 | |||||||||||||
Intraoperative | |||||||||||||
Neurological | |||||||||||||
Pediatric | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, 11 | ||||||
Small Organ | |||||||||||||
(Note 1) | P | P | P | P | P | BMDC | Note 2,3,4,5,6,7,8,10, 11,14, | ||||||
16, 18 | |||||||||||||
Neonatal Cephalic | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, 11 | ||||||
Adult Cephalic | P | P | P | P | P | ||||||||
Cardiac | P | P | P | P | P | BMDC | Note 15 | ||||||
Trans-esophageal | |||||||||||||
Transrectal | |||||||||||||
Transvaginal | |||||||||||||
Transurethral | |||||||||||||
Intravascular | |||||||||||||
Peripheral vessel | P | P | P | P | P | BMDC | Note 2,3,4,5,6, 7,8,10, 11, | ||||||
14.15 | |||||||||||||
Laparoscopic | |||||||||||||
Musculo-skeletal | |||||||||||||
Conventional | P | P | P | P | P | BMDC | Note 2,3,4,5,6,7,8,10, 11, 14 | ||||||
Musculo-skeletal | |||||||||||||
Superficial | P | P | P | P | P | BMDC | Note 2,3,4,5,6,7,8,10, 11, 14 | ||||||
Other (specify) |
N = new indication: P = previously cleared by FDA K# 053085, K072786, K081148, K093812, K111674, K121138, K130739
Additional Comments:
Note 1 For example: breast, testes, thyroid, penis, prostate, etc.
- Note 3 SieClear multi-view spatial compounding
- 3-Scape real-time 3D imaging Note 5 B&W SieScape panoramic imaging
- Note 7 Nole 9 Abdomen and Vascular
- Note 11 Advanced Sieclear spatial compounding
- Note 15 AHP
Note 18 VTI (Virtual Touch Imaging)
- Nole 2 Ensemble tissue harmonic imaging Tissue Equalization Technology Note 4
- Note 6 Cadence contrast agent imaging Power SieScape panoramic imaging Note B
- Note 10
- Clarify VE vascular enhancement technology Note 14 eSie™ Touch elasticity imaging / FTI
- Note 16 Custom Tissue Imaging
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Heatth; Office of In Vitro Diagnostics and Radiological Health
510(k)_
Page 6 of _
S-Family 510(k) Submission
Page 22 of 64
e In Vitro Diagnostics and Radiological
14
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
Device Name:
14L5 Multi-D Array Transducer For Use On ACUSON S1000, S2000, S3000 Ultrasound Systems
Intended Use:
Use: | Ultrasound imaging or fluid flow analysis of the human body as follows: | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Mode of Operation | |||||||||||
Clinical Application | A | B | M | PWD | CWD | Color | |||||
Doppler | Amplitude | ||||||||||
Doppler | Color | ||||||||||
Velocity | |||||||||||
Imaging | Combined | ||||||||||
(Specify) | Other | ||||||||||
(Specify) | |||||||||||
Ophthalmic | |||||||||||
Fetal | |||||||||||
Abdominal | |||||||||||
Intraoperative | |||||||||||
Note 9 | |||||||||||
Intraoperative | |||||||||||
Neurological | |||||||||||
Pediatric | |||||||||||
Small Organ | |||||||||||
(Note 1) | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | ||||
11, 14, 16 | |||||||||||
Neonatal Cephalic | |||||||||||
Adult Cephalic | |||||||||||
Cardiac | |||||||||||
Trans-esophageal | |||||||||||
Transrectal | |||||||||||
Transvaginal | |||||||||||
Transurethral | |||||||||||
Intravascular | |||||||||||
Peripheral vessel | P | P | P | P | P | BMDC | Note 2,3,4,5,6, | ||||
7.8,10. 11. 14 | |||||||||||
Laparoscopic | |||||||||||
Musculo-skeletal | |||||||||||
Conventional | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | ||||
11, 14 | |||||||||||
Musculo-skeletal | |||||||||||
Superficial |
N = new indication; P = previously cleared by FDA K# 063085, K072788, K080334, K093812, K111674, K121138
Additional Comments:
Note 1 For example: breast, testes, thyroid, penis, prostate, etc.
Note 3 SieClear multi-view spatial compounding
3-Scape real-time 3D imaging Note 5
- Note 7 B&W SieScape panoramic imaging
- Note 9 Abdomen and Vascular
Nole 11 Advanced Sieclear spatial compounding
Note 16 Custom Tissue Imaging
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Health; Office of In Vitro Diagnostics and Radiological Health
510fk)_
.
S-Family 510(k) Submission
Note 4 Tissue Equalization Technology
Note 6 Cadence contrast agent imaging
Note 8 Power SieScape panoramic imaging
-
Note 10 Clarify VE vascular enhancement technology
Ensemble tissue harmonic imaging -
Note 14 eSie™ Touch elasticity imaging / FTI
Note 18 Virtual Touch Imaging
Note 2
15
510 (k) Number (if known):
Device Name:
4P1 Phased Array Transducer For Use On ACUSON S1000, S2000, S3000 Ultrasound Systems
Intended Use: | Ultrasound imaging or fluid flow analysis of the human body as follows: | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mode of Operation | |||||||||||||
Clinical Application | A | B | M | PWD | CWD | Color | |||||||
Doppler | Amplitude | ||||||||||||
Doppler | Color | ||||||||||||
Velocity | |||||||||||||
Imaging | Combined | ||||||||||||
(Specify) | Other | ||||||||||||
(Specify) | |||||||||||||
Ophthalmic | |||||||||||||
Fetal | P | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10 | ||||
Abdominal | P | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10 | ||||
Intraoperative | |||||||||||||
Note 9 | |||||||||||||
Intraoperative | |||||||||||||
Neurological | |||||||||||||
Pediatric | |||||||||||||
Small Organ | |||||||||||||
Neonatal Cephalic | |||||||||||||
Adult Cephalic | P | P | P | P | P | P | P | BMDC | Note 2.3,4,5,7,8,10 | ||||
Cardiac | P | P | P | P | P | P | P | BMDC | Note 2,3,4,5,6,7,8,10 | ||||
Trans-esophageal | |||||||||||||
Transrectal | |||||||||||||
Transvaginal | |||||||||||||
Transurethral | |||||||||||||
Intravascular | |||||||||||||
Peripheral vessel | |||||||||||||
Laparoscopic | |||||||||||||
Musculo-skeletal | |||||||||||||
Conventional | |||||||||||||
Musculo-skeletal | |||||||||||||
Superficial | |||||||||||||
Other (specify) |
N = new indication; P = previously cleared by FDA K# 063803, K072786, K081148, K090334, K093812, K111674, K121138
Additional Comments:
Ensemble tissue harmonic imaging Note 2
Note 3 SieClear multi-view spatial compounding
Note 4 Tissue Equalization Technology
Note 5 3-Scape real-time 3D imaging
- Note 6 Cadence contrast agent imaging
Note 7 B&W SieScape panoramic imaging
Note 8 Power SieScape panoramic imaging
Note O Abdomen and Vascular
Note 10 Clarify VE vascular enhancement technology
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Heath; Office of In Vitro Diagnostics and Radiological Health 510(k)_
Page 8 ot _
S-Family 510(k) Submission
Page 24 of 64
16
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
Device Name:
6C2 Curved Array Transducer For Use On ACUSON $1000, S2000, S3000 Ultrasound Systems'
Intended Use:
Ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | ||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Other | |||||||||||
(Specify) | ||||||||||||
Ophthalmic | ||||||||||||
Fetal | P | P | p | P | P | BMDC | Note 2,3,4,5,7,8,10, | |||||
11 | ||||||||||||
Abdominal | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | |||||
11, 14, 16, 17 | ||||||||||||
Intraoperative | ||||||||||||
Nore g | ||||||||||||
Intraoperative | ||||||||||||
Neurologica! | ||||||||||||
Pediatric | P | P | P | p | p | BMDC | Note 2,3,4,5,7,8,10. | |||||
11 | ||||||||||||
Small Organ | ||||||||||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | ||||||||||||
Trans-esophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral vessel | P | ក្រ | P | P | p | BMDC | Note 2.3,4.5,7,8,10, | |||||
11 | ||||||||||||
Laparoscopic | ||||||||||||
Musculo-skeletal | ||||||||||||
Conventional | ||||||||||||
Musculo-skeletal | ||||||||||||
Superficial | ||||||||||||
Other (specify) |
N = new indication; P = previously cleared by FDA K# 063085, K072786, K08142, K090334, K111674, K121138
Additional Comments:
- Note 2 Ensemble tissue harmonic imaging
Tissue Equalization Technology Note 4
B&W SieScape panoramic imaging Note 7
- Note 9 Abdomen and Vascular
- Note 11 Advanced Sieclear spatial compounding
- Note 16 Custom Tissue Imaging
Note 3 SieClear multi-view spatial compounding
- 3-Scape real-time 3D imaging Note 2
Note 8 Power SieScape panoramic imaging
Note 10 Clarify VE vascular enhancement technology
Note 14 eSie™ Touch elasticity imaging / FTI
Note 17 eSie Fusion
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Health; Office of In Vitro Diagnostics and Radiological Health
510(k)
Page 9 ol _
17
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
Device Name:
4C1 Curved Array Transducer For Use On ACUSON S1000, S2000, S3000 Ultrasound Systems
Intended Use:
Ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | |||||
Doppler | Amplitude | ||||||||||
Doppler | Color | ||||||||||
Velocity | |||||||||||
Imaging | Combined | ||||||||||
(Specify) | Other | ||||||||||
(Specify) | |||||||||||
Ophthalmic | |||||||||||
Fetal | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10,11 | |||
Abdominal | P | P | P | P | P | P | BMDC | Note2,3,4,5,6,7,8,10, | |||
11, 14, 16, 17, 18 | |||||||||||
Intraoperative | |||||||||||
Note 9 | |||||||||||
Intraoperative | |||||||||||
Neurological | |||||||||||
Pediatric | |||||||||||
Small Organ | P | P | P | P | P | P | BMDC | ||||
Neonatal Cephalic | |||||||||||
Adult Cephalic | |||||||||||
Cardiac | P | P | P | P | P | P | BMDC | ||||
Trans-esophageal | |||||||||||
Transrectal | |||||||||||
Transvaginal | |||||||||||
Transurethral | |||||||||||
Intravascular | |||||||||||
Peripheral vessel | P | P | P | P | P | P | BMDC | ||||
Laparoscopic | |||||||||||
Musculo-skeletal | |||||||||||
Conventional | |||||||||||
Musculo-skeletal | |||||||||||
Superficial | |||||||||||
Other (specify) |
N = new indication; P = previously cleared by FDA KA 063085, K072786, K081148, K093812, K111674, K121138, K130739
Additional Comments:
Note 2 Ensemble tissue harmonic imaging
Note 4 Tissue Equalization Technology
- Cadence contrast agent imaging Note 6
Note 8 Power SieScape panoramic imaging
Note 10 Clarify VE vascular enhancement technology
- eSie™ Touch elasticity imaging / FTI Note 14
- Note 17 eSie Fusion
- Note 3 SieClear multi-view spatial compounding
- 3 Scape real-time 3D imaging Note 5
- B&W SieScape panoramic imaging
- Note 9 Abdomen and Vascular
- Note 11 Advanced Sieclear spatial compounding
(PLEASE DO NOT WRITE BELOW THIS LINE.CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Ragiological Health (OIR)
Division Sign-Off Division of Radiological Heath; Office of In Vitro Diagnostics and Radiological Health 510(k)_
S-Family 510(k) Submission
Page 26 of 64
Page 10 ot _
- Note 7
- Note 16 Custom Tissue Imaging
- Note 18 VTI
18
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
Device Name:
6C1HD Curved Array Transducer For Use On ACUSON S2000, S3000 Ultrasound Systems
Intended Use:
Ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | ||||
Doppler | Amplitude | |||||||||
Doppler | Color | |||||||||
Velocity | ||||||||||
Imaging | Combined | |||||||||
(Specify) | Other | |||||||||
(Specify) | ||||||||||
Ophthalmic | ||||||||||
Fetal | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8.10. | ||
11 | ||||||||||
Abdominal | P | P | P | P | P | P | BMDC | Note2,3,4,5,6,7,8, | ||
10, 11, 14, 16, 17, | ||||||||||
18 | ||||||||||
Intraoperative | ||||||||||
Note 9 | ||||||||||
Intraoperative | ||||||||||
Neurological | ||||||||||
Pediatric | ||||||||||
Small Organ | P | P | P | P | P | P | BMDC | |||
Neonatal Cephalic | ||||||||||
Adult Cephalic | ||||||||||
Cardiac | P | P | P | P | P | P | BMDC | |||
Trans-esophageal | ||||||||||
Transrectal | ||||||||||
Transvaginal | ||||||||||
Transurethral | ||||||||||
Intravascular | ||||||||||
Peripheral vessel | P | P | P | P | P | P | BMDC | |||
Laparoscopic | ||||||||||
Musculo-skeletal | ||||||||||
Conventional | ||||||||||
Musculo-skeletal | ||||||||||
Superficial | ||||||||||
Other (specify) |
N = new indication; P = previously cleared by FDA K# 111674, K121138, K130739
Additional Comments:
- Note 2 Ensemble tissue harmonic imaging
- Note 4 Tissue Equalization Technology
- Note 6 Cadence contrast agent imaging
- Power SieScape panoramic imaging Note 8
- Clarify VE vascular enhancement technology Note 10 eSie™ Touch elasticity imaging / FTI
- Note 14
- Note 17 eSie Fusion
Note 3 SieClear multi-view spatial compounding
- Note 5 3-Scape real-time 3D imaging
- Note 7 B&W SieScape panoramic imaging
- Note 9 Abdomen and Vascular
Advanced Sieclear spatial compounding Note 11
- Note 16 Custom Tissue Imaging
- Note 18 VTI
{PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Health: Office of In Vitro Diagnostics and Radiological Health
510(k)_
.
Page 11 of ___________________________________________________________________________________________________________________________________________________________________
S-Family 510(k) Submission
Page 27 of 64
19
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
8C3HD Curved Array Transducer For Use On ACUSON S2000, $3000 Ultrasound Systems
Ultrasound imaging or fluid flow analysis of the human body as follows:
Device Name: Intended Use:
| Clinical Application | A | B | M | PWD | CWD | Color
Doppler | Amplitude
Doppler | Color
Velocity
Imaging | Combined
(Specify) | Other
(Specify) |
|--------------------------|------------|---|---|-----|-----|------------------|----------------------|------------------------------|-----------------------|------------------------------------|
| | Ophthalmic | | | | | | | | | |
| Fetal | | P | P | P | | P | P | | BMDC | Note 2,3,4,5,7,8,10,
11 |
| Abdominal | | P | P | P | | P | P | | BMDC | Note 2.3.4.5,7,8,10,
11, 14, 16 |
| Intraoperative
Note 9 | | | | | | | | | | |
| Intraoperative
Note 9 | |||||||
---|---|---|---|---|---|---|---|
Intraoperative | |||||||
Neurological | |||||||
Pediatric | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10 |
11 | |||||||
Small Organ | P | P | P | P | P | BMDC | |
Neonatal Cephalic | |||||||
Adult Cephalic | |||||||
Cardiac | |||||||
Trans-esophageal | |||||||
Transrectal | |||||||
Transvaginal | |||||||
Transurethral | |||||||
Intravascular | |||||||
Peripheral vessel | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10 |
11 | |||||||
Laparoscopic | |||||||
Musculo-skeletal | |||||||
Conventional | |||||||
Musculo-skeletal | |||||||
Superficial | |||||||
Other (specify) |
N = new indication: P = previously cleared by FDA K#121138. K#130739
Additional Comments
- Note 2 Ensemble tissue harmonic imaging
- Note 4 Tissue Equalization Technology
- Cadence contrast agent imaging Note 6
Note 16 Custom Tissue Imaging
- Note 8 Power SieScape panoramic imaging
- Note 11 Advanced Sieclear spatial compounding
- Note 5 3-Scape real-time 3D imaging
- B&W SieScape panoramic imaging Note 7
- Note 10 Clarify VE vascular enhancement technology
Note 14 eSie™ Touch efasticity imaging / FTI
SieClear multi-view spatial compounding
(PLEASE OO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Nole 3
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Health; Office of In Vitro Diagnosiics and Radiological Health
510(k)_
Page 12 of ___________________________________________________________________________________________________________________________________________________________________
S-Family 510(k) Submission
Page 28 of 64
- 20 - 5.0
20
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
Device Name:
4V1 Phased Array Transducer For Use On ACUSON S1000, S2000, S3000 Ultrasound Systems
Intended Use:
Ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | ||||
Doppler | Amplitude | |||||||||
Doppler | Color | |||||||||
Velocity | ||||||||||
Imaging | Combined | |||||||||
(Specify) | Other | |||||||||
(Specify) | ||||||||||
Ophthalmic | ||||||||||
Fetal | P | P | P | P | P | BMDC | Note 2.3,4.5,7.8,10 | |||
Abdominal | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, |
-
- 17 |
| Intraoperative | | | | | | | | | | |
| Intraoperative
Neurological | | | | | | | | | | |
| Pediatric | | | | | | | | | | |
| Small Organ | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | |
| Cardiac | | | | | | | | | | |
| Trans-esophageal | | | | | | | | | | |
| Transrectal | | | | | | | | | | |
| Transvaginal | | | | | | | | | | |
| Transurethrai | | | | | | | | | | |
| Intravascular | | | | | | | | | | |
| Peripheral vessel | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | |
| Musculo-skeletal
Conventional | | | | | | | | | | |
| Musculo-skeletal
Superficial | | | | | | | | | | |
| Other (specify) | | | | | | | | | | |
- 17 |
N = new indication; P = previously cleared by FDA K# 063085, K072786, K092142, K090334, K111674, K121138
Additional Comments:
- Note 2 Ensemble tissue harmonic imaging
- Tissue Equalization Technology Note 4
- B&W SieScape panoramic imaging Note 7
- Clarify VE vascular enhancement technology Note 10
- Note 14 eSie™ Touch elasticity imaging / FTI
- Note 3 SieClear multi view spatial compounding Note 5 3-Scape real-time 3D imaging
- Power SieScape panoramic imaging Note 8
- Note 11 Advanced Sieclear spatial compounding
Note 16 Custom Tissue Imaging
Note 17 eSie Fusion
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
510(k)_
Page 13 of ___________________________________________________________________________________________________________________________________________________________________
Division Sign-Off Division of Radiological Health; Office of In Viro Diagnostics and Radiological Health
21
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
10V4 Phased Array Transducer For Use On ACUSON S1000, S2000, S3000 Ultrasound Systems
Device Name: Intended Use:
Ultrasound imaging or fluid flow analysis of the human body as follows:
Intended Use:
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | ||||
Doppler | Amplitude | |||||||||
Doppler | Color | |||||||||
Velocity | ||||||||||
Imaging | Combined | |||||||||
(Specify) | Other | |||||||||
(Specify) | ||||||||||
Ophthalmic | ||||||||||
Fetal | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10 | ||
Abdominal | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10 | ||
Intraoperative | ||||||||||
Intraoperative | ||||||||||
Neurological | ||||||||||
Pediatric | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10 | ||
Small Organ | ||||||||||
Neonatal Cephalic | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10 | ||
Adult Cephalic | ||||||||||
Cardiac | P | P | P | P | P | P | BMDC | Note 3.4 | ||
Trans-esophageal | ||||||||||
Transrectal | ||||||||||
Transvaginal | ||||||||||
Transurethral | ||||||||||
Intravascular | ||||||||||
Peripheral vessel | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10 | ||
Laparoscopic | ||||||||||
Musculo-skeletal | ||||||||||
Conventional | ||||||||||
Musculo-skeletal | ||||||||||
Superficial | ||||||||||
Other (specify) |
N = new indication, P = previously cleared by FDA K# 063085, K072786, K081148, K092812, K111674, K121138
Additional Comments
Ensemble tissue harmonic imaging Note 2
Note 3 SieClear multi view spatial compounding
Tissue Equalization Technology Nole 4
3-Scape real-time 3D imaging Note 5
Note 7 B&W SieScape panoramic imaging
Note 8 Power SieScape panoramic imaging Note 10 Clarify VE vascular enhancement technology
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Heath; Office of In Vitro Diagnostics and Radiological Health
510(k)_
Page 14 of
22
510 (k) Number (if known):
14L5 SP Linear Array Transducer For Use On ACUSON S1000, S2000, S3000 Device Name: Ultrasound Systems Indications For Use: Diagnostic imaging or fluid flow analysis of the human body as follows: Mode of Operation Clinical Application Color Color Amplitude Combined Other A B M PWD CWD Velocity Doppler Doppler (Specify) (Specify) Imaging Ophthalmic Fetal Abdominal Intraoperative Note P p P P P BMDC (Note 9) 2.3.4.5.7.8.10.11 Intraoperative Neurological Pediatric Small Organ Note 2,3,4,5,7,8,10, P P ర్లు P P BMDC (Note 1) 11,14, 16 Neonatal Cephalic Adult Cephalic p P Cardiac P P 0. BMDC Note 15 Transesophageal Transrectal Transvaginal Transurethral Intravascular Note2,3,4,5,6 Peripheral vessel P P P b P BMDC 7.8.10, 11,14,15 Laparoscopic Musculo-skeietai Note 2,3,4,5,7,8,10, p P P p P BMDC Conventional 11.14 Musculo-skeletal -Superficial Other (specify)
N = new indication; P = previously cleared by FDA K# 063085, K072786, K08142, K09034, K111674, K121138
Additional Comments:
Note 1 For example: breast, testes, thyroid, penis, prostate, etc.
Note 3 SieClear multi-view spatial compounding
3-Scape real-time 3D imaging Note 5
B&W SieScape panoramic imaging Note 7
Note 9 For example: vascular, abdominal
Note 11 Advanced Sieclear spatial compounding
Note 15 AHP
te 15 AHP
Note 2 Ensemble tissue harmonic imaging Tissue Equalization Technology Note 4 Note 6 Cadence contrast agent imaging Note 8 Power SieScape panoramic imaging Note 10 Clarify VE vascular enhancement technology Note 14 eSie™ Touch elasticity imaging / FTI
PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Health: Office of In Viro Diagnostics and Radiological Health
510(k)
Page 15 of ___________________________________________________________________________________________________________________________________________________________________
S-Family 510(k) Submission
Page 31 of 64
- Note 16 Custom Tissue Imaging
IPLEASE DO NOT WRITE BELOW THIS LINE.CONTINUE ON ANOTHER PAGE IF NEEDED)
23
.
S-Family Ultrasound Systems 510(k) Submission
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
7CF2 Curved array mechanical 3D transducer For Use On ACUSON S1000, S2000, S3000 Ultrasound Systems
Device Name: Intended Use:
Ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | ||||
Doppler | Amplitude | |||||||||
Doppler | Color | |||||||||
Velocity | ||||||||||
Imaging | Combined | |||||||||
(Specify) | Other | |||||||||
(Specify) | ||||||||||
Ophthalmic | ||||||||||
Fetal | P | P | P | P | P | BMDC | Note 2.3,4,5,7,8,10. | |||
11,13 | ||||||||||
Abdominal | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, |
- 13 |
| Intraoperative | | | | | | | | | | |
| Intraoperative
Neurological | | | | | | | | | | |
| Pediatric | | | | | | | | | | |
| Small Organ | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | |
| Cardiac | | | | | | | | | | |
| Trans-esophageal | | | | | | | | | | |
| Transrectal | | | | | | | | | | |
| Transvaginal | | | | | | | | | | |
| Transurethral | | | | | | | | | | |
| Intravascular | | | | | | | | | | |
| Peripheral vessel | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | |
| Musculo-skeletal
Conventional | | | | | | | | | | |
| Musculo-skeletal
Superficial | | | | | | | | | | |
| Other (specify) | | | | | | | | | | |
N = new indication; P = previously cleared by FDA K# 063803, K072786, K08142, K090334, K111674, K121138
Additional Comments:
Note 2 Ensemble tissue harmonic imaging
SieClear multi-view spatial compounding Note 3
Tissue Equalization Technology Note 4
Note 5 3-Scape real-time 3D imaging
B&W SieScape panoramic imaging Note 7
Note 8 Power SieScape panoramic imaging
Note 10 Clarify VE vascular enhancement technology
Note 11 Advanced Sieclear spatial compounding
Note 13 STIC
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Health; Office of In Vitro Dragnostics and Radiological Health
51D(k)________________________________________________________________________________________________________________________________________________________________________
Page 16 o! ___________________________________________________________________________________________________________________________________________________________________
S-Family 510(k) Submission
Page 32 of 64
24
S-Family Ultrasound Systems 510(k) Submission
Diagnostic Uitrasound Indications for Use Form
510 (k) Number (if known):
Device Name:
7CF1 Curved array mechanical 3D transducer For Use On ACUSON S1000, S2000, S3000 Ultrasound Systems
Ultrasound imaging or fluid flow analysis of the human body as follows: Intended Use:
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | ||||
Doppler | Amplitude | |||||||||
Doppler | Color | |||||||||
Velocity | ||||||||||
Imaging | Combined | |||||||||
(Specify) | Other | |||||||||
(Specify) | ||||||||||
Ophthalmic | ||||||||||
Fetal | N | N | N | N | N | BMDC | Note 2,3,4,5,7,8,10, | |||
11.13 | ||||||||||
Abdominal | N | N | N | N | N | BMDC | Note 2,3,4,5,7,8,10, | |||
11, 13 | ||||||||||
Intraoperative | ||||||||||
Intraoperative | ||||||||||
Neurological | ||||||||||
Pediatric | ||||||||||
Small Organ | ||||||||||
Neonatal Cephalic | ||||||||||
Adult Cephalic | ||||||||||
Cardiac | ||||||||||
Trans-esophageal | ||||||||||
Transrectal | ||||||||||
Transvaginal | ||||||||||
Transurethral | ||||||||||
Intravascular | ||||||||||
Peripheral vessel | ||||||||||
Laparoscopic | ||||||||||
Musculo-skeletal | ||||||||||
Conventional | ||||||||||
Musculo-skeletal | ||||||||||
Superficial | ||||||||||
Other (specify) |
N = new indication; P = previously cleared by FDA K# 063803, K072786, K081148, K090334, K111874, K121138
Additional Comments:
Note 2 Ensemble tissue harmonic imaging
SieClear multi-view spatial compounding Note 3
Tissue Equalization Technology Note 4
3-Scape real-time 3D imaging Note 5
B&W SieScape panoramic imaging Note 7
Note 8 Power SieScape panoramic imaging
Note 10 Clarify VE vascular enhancement technology
Note 11 Advanced Sieclear spatial compounding
Note 13 STIC
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Health; Office of In Vitro Diagnostics and Radiological Health
510(k)
Page 15 of ___________________________________________________________________________________________________________________________________________________________________
S-Family 510(k) Submission
Page 33 of 64
25
S-Family Ultrasound Systems 510(k) Submission
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known);
9EVF4 Curved Array Transducer For Use On ACUSON S1000, S2000, S3000 Ultrasound Systems
Device Name: Intended Use:
Ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color Doppler | Amplitude Doppler | Color Velocity Imaging | Combined (Specify) | Other (Specify) |
Ophthalmic | ||||||||||
Fetal | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8, 10,11, 13 | |||
Abdominal | ||||||||||
Intraoperative | ||||||||||
Intraoperative | ||||||||||
Neurological | ||||||||||
Pediatric | ||||||||||
Small Organ | ||||||||||
Neonatal Cephalic | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8, 10,11 | |||
Adult Cephalic | ||||||||||
Cardiac | ||||||||||
Trans-esophageal | ||||||||||
Transrectal | ||||||||||
Transvaginal | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8, 10,11 | |||
Transurethral | ||||||||||
Intravascular | ||||||||||
Peripheral vessel | ||||||||||
Laparoscopic | ||||||||||
Musculo-skeletal | ||||||||||
Conventional | ||||||||||
Musculo-skeletal | ||||||||||
Superficial | ||||||||||
Other (specify) |
N = new indication: P = previously cleared by FDA X# 063803, K072786, K09142, K090334, K111674, K121138
Additional Comments
Note 2 Ensemble tissue harmonic imaging
Note 3 SieClear multi-view spatial compounding
Note 4 Tissue Equalization Technology
Note 5 3-Scape real-time 3D imaging
Note 7 B&W SieScape panoramic imaging
Note 8 Power SieScape panoramic imaging
Note 10 Clarify VE vascular enhancement technology
Note 11 Advanced Sieclear spatial compounding
Note 13 STIC
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Health; Office of In Viro Diagnostics and Radiological Health
510(k)_
Page 17 of ___________________________________________________________________________________________________________________________________________________________________
S-Family 510(k) Submission
Page 34 of 64
26
510 (k) Number (if known):
Device Name:
V5Ms Multiplane TEE Transducer For Use On ACUSON S1000, S2000, S3000 Ultrasound Systems Ultrasound imaging or fluid flow analysis of the human body as follows:
Intended Use: | Ultrasound imaging or fluid flow analysis of the human body as follows: | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mode of Operation | |||||||||||||
Clinical Application | A | B | M | PWD | CWD | Color | |||||||
Doppler | Amplitude | ||||||||||||
Doppler | Color | ||||||||||||
Velocity | |||||||||||||
Imaging | Combined | ||||||||||||
(Specify) | Other | ||||||||||||
(Specify) | |||||||||||||
Ophthalmic | |||||||||||||
Fetal | |||||||||||||
Abdominal | |||||||||||||
Intraoperative | |||||||||||||
Intraoperative | |||||||||||||
Neurological | |||||||||||||
Pediatric | |||||||||||||
Small Organ | |||||||||||||
Neonatal Cephalic | |||||||||||||
Adult Cephalic | |||||||||||||
Cardiac | |||||||||||||
Trans-esophageal | P | P | P | P | P | P | BMDC | Note 4 | |||||
Transrectal | |||||||||||||
Transvaginal | |||||||||||||
Transurethral | |||||||||||||
Intravascular | |||||||||||||
Peripheral vessel | |||||||||||||
Laparoscopic | |||||||||||||
Musculo-skeletal | |||||||||||||
Conventional | |||||||||||||
Musculo-skeletal | |||||||||||||
Superficial | |||||||||||||
Other (specify) |
N = new indication: P = previously cleared by FDA K# 063803, K072786, K081148, K082812, K111674, K121138
Additional Comments:
Note 4 Tissue Equalization Technology
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Health; Office of In Vitro Diagnosiics and Radiological Health
.
510(k)_
Page 18 01 ___________________________________________________________________________________________________________________________________________________________________
27
510 (k) Number (if known):
Device Name:
. •
18L6 HD Lincar Array Transducer For Use On ACUSON $1000, S2000, S3000 Ultrasound Systems
Intended Use: | Ultrasound imaging or fluid flow analysis of the human body as follows: | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mode of Operation | ||||||||||||||
Clinical Application | A | B | M | PWD | CWD | Color | ||||||||
Doppler | Amplitude | |||||||||||||
Doppler | Color | |||||||||||||
Velocity | ||||||||||||||
Imaging | Combined | |||||||||||||
(Specify) | Other | |||||||||||||
(Specify) | ||||||||||||||
Ophthalmic | ||||||||||||||
Fetal | ||||||||||||||
Abdominal | ||||||||||||||
Intraoperative | ||||||||||||||
Intraoperative | ||||||||||||||
Neurological | ||||||||||||||
Pediatric | ||||||||||||||
Small Organ | ||||||||||||||
(Note 1) | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | ||||||
11.14. 16 | ||||||||||||||
Neonatal Cephalic | ||||||||||||||
Adult Cephalic | ||||||||||||||
Cardiac | P | P | P | P | P | P | BMDC | Note 15 | ||||||
Trans-esophageal | ||||||||||||||
Transrectal | ||||||||||||||
Transvaginal | ||||||||||||||
Transurethral | ||||||||||||||
Intravascular | ||||||||||||||
Peripheral vessel | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | ||||||
11,14,15 | ||||||||||||||
Laparoscopic | ||||||||||||||
Musculo-skeletal | ||||||||||||||
Conventional | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7.8.10. | ||||||
11.14 | ||||||||||||||
Musculo-skeletal | ||||||||||||||
Superficial | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10, | ||||||
11.14 | ||||||||||||||
Other (specify) |
N = new indication; P = previously cleared by FDA K081148, K080334, K093812, K111674, K121138
Additional Comments
Note 1 For example: breast, testes, thyroid, penis, prostate, etc.
Ensemble tissue harmonic imaging Note 2
SieClear multi-view spatial compounding Note 3
Nole 4 Tissue Equalization Technology
Note 3-Scape real-time 3D imaging
B&W SieScape panoramic imaging Note 7
Power SieScape panoramic imaging Note 8
Clarify VE vascular enhancement technology Note 10
Note 11 Advanced Sieclear spatial compounding
Note 14 eSie™ Touch elasticity imaging / FTI
(PLEASE DO NOT WRITE BELOW THIS LINE.CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Div.sion of Radiological Health; Office of In Viro Diagnostics and Radiological Health
510(k)________________________________________________________________________________________________________________________________________________________________________ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Page 19 of ___________________________________________________________________________________________________________________________________________________________________
S-Family 510(k) Submission
Page 36 of 64
- Note 15 AHP
Note 16 Custom Tissue Imaging
28
S-Family Ultrasound Systems 510(k) Submission
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
8V3 Phased Array Transducer For Use On ACUSON S1000, S2000, S3000 Uitrasound Systems
Device Name: Intended Use:
Ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | ||||
Doppler | Amplitude | |||||||||
Doppler | Color | |||||||||
Velocity | ||||||||||
Imaging | Combined | |||||||||
(Specify) | Other | |||||||||
(Specify) | ||||||||||
Ophthalmic | ||||||||||
Fetal | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10 | ||
Abdominal | ||||||||||
Intraoperative | ||||||||||
Intraoperative | ||||||||||
Neurological | ||||||||||
Pediatric | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8,10 | ||
Small Organ | ||||||||||
Neonatal Cephalic | P | P | P | P | P | P | BMDC | Note 2,3,4,5,7,8.10 | ||
Adult Cephalic | ||||||||||
Cardiac | P | P | P | P | P | P | BMDC | Note 3,4,6 | ||
Trans-esophageal | ||||||||||
Transrectal | ||||||||||
Transvaginal | ||||||||||
Transurethral | ||||||||||
Intravascular | ||||||||||
Peripheral vessel | ||||||||||
Laparoscopic | ||||||||||
Musculo-skeletal | ||||||||||
Conventional | ||||||||||
Musculo-skeletal | ||||||||||
Superficial | ||||||||||
Other (specify) | ||||||||||
Neonatal Cardiac | P | P | P | P | P | P | BMDC | Note 3,4,6 |
N = new indicalion; P = previously cleared by FDA K# 063085, K072786, K081148, K082112, K111674, K121138
Additional Comments
Ensemble tissue harmonic imaging Note 2
SieClear multi-view spatial compounding Note 3
Tissue Equalization Technology Note 4
3-Scape real-time 3D imaging Note 5
Cadence contrast agent imaging Note 6
B&W SieScape panoramic imaging Note 7
Note 8 Power SieScape panoramic imaging
Note 10 Clarify VE vascular enhancement technology
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Heath; Office of In Vitro Diagnostics and Radiological Health
510(k)________________________________________________________________________________________________________________________________________________________________________
Page 20 ol ___________________________________________________________________________________________________________________________________________________________________
S-Family 510(k) Submission
Page 37 of 64
29
510 (k) Number (if known):
Device Name:
4V1c Phased Array Transducer For Use On ACUSON S1000, S2000, S3000 Ultrasound Systems
Intended Use:
Ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | ||||
Doppler | Amplitude | |||||||||
Doppler | Color | |||||||||
Velocity | ||||||||||
Imaging | Combined | |||||||||
(Specify) | Other | |||||||||
(Specify) | ||||||||||
Ophthalmic | ||||||||||
Fetal | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10 | ||
Abdominal | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10 | ||
Intraoperative | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10 | ||
Intraoperative | ||||||||||
Neurological | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10 | ||
Pediatric | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10 | ||
Small Organ | ||||||||||
Neonatal Cephalic | ||||||||||
Adult Cephalic | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10 | ||
Cardiac | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10 | ||
15 | ||||||||||
Trans-esophageal | ||||||||||
Transrectal | ||||||||||
Transvaginal | ||||||||||
Transurethral | ||||||||||
Intravascular | ||||||||||
Peripheral vessel | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10 | ||
15 | ||||||||||
Laparoscopic | ||||||||||
Musculo-skeletal | ||||||||||
Conventional | ||||||||||
Musculo-skeletal | ||||||||||
Superficial | ||||||||||
Other (specify) | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10 |
N = new indication, P = previously cleared by FDA K# : 052410, 051139, 041319, 132114, 022567, (6130834, K093812, K111674, K121138
Additional Comments:
Note 2 Ensemble tissue harmonic imaging
SieClear multi-view spatial compounding Note 3
Note 4 Tissue Equalization Technology
Note ર 3-Scape real-time 3D imaging
Note 6 Cadence contrast agent imaging
B&W SieScape panoramic imaging Note 7
Power SieScape panoramic imaging Note 8
Note 10 Clarify VE vascular enhancement technology
Note 15 AHP
(PLEASE DO NOT WRITE BELOW THIS LINE.CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Ragiological Health (OIR)
Division Sign-Off Division of Radiological Heath; Office of In Vitro Diagnostics and Radiological Health
510(k)_
Page 21 of ___________________________________________________________________________________________________________________________________________________________________
30
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
6L3 Transducer For Use On ACUSON S1000, S2000, S3000 Ultrasound Systems Device Name: Ultrasound imaging or fluid flow analysis of the human body as follows: Intended Use:
Mode of Operation | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | |||||
Doppler | Amplitude | ||||||||||
Doppler | Color | ||||||||||
Velocity | |||||||||||
Imaging | Combined | ||||||||||
(Specify) | Other | ||||||||||
(Specify) | |||||||||||
Ophthalmic | |||||||||||
Fetal | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10, | |||
11 | |||||||||||
Abdominal | |||||||||||
Intraoperative | |||||||||||
Note 9 | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10, | |||
11 | |||||||||||
Intraoperative | |||||||||||
Neurological | |||||||||||
Pediatric | |||||||||||
Small Organ | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10, | |||
1 | |||||||||||
Neonatal Cephalic | |||||||||||
Adult Cephalic | |||||||||||
Cardiac | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10 | |||
15 | |||||||||||
Trans-esophageal | |||||||||||
Transrectal | |||||||||||
Transvaginal | |||||||||||
Transurethral | |||||||||||
Intravascular | |||||||||||
Peripheral vessel | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10, | |||
11 15 | |||||||||||
Laparoscopic | |||||||||||
Musculo-skeletal | |||||||||||
Conventional | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10, | |||
11 | |||||||||||
Musculo-skeletal | |||||||||||
Superficial | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10, | |||
11 | |||||||||||
Other (specify) |
N = new indication: P = previously cleared by FDA K# x 052410, 031139, 03111, 022567, 002807, 973767, 063085, K093812, K111674. K121138
Additional Comments
- Note 2 Ensemble tissue harmonic imaging
Note 4 Tissue Equalization Technology
Cadence contrast agent imaging Note 6
Power SieScape panoramic imaging Note 8
Note 11 Advanced Sieclear spatial compounding
- Note 3 SieClear multi-view spatial compounding
Note 5 3-Scape real-time 3D imaging
Note 7 B&W SieScape panoramic imaging
Note 10 Clarify VE vascular enhancement technology
Note 15 AHP
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Heath: Office of In Vitro Diagnostics and Radiological Health
510(k)_
Page 22 of _____
S-Family 510(k) Submission
Page 39 of 64
31
S-Family Ultrasound Systems 510(k) Submission
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
EV8C4 Transducer For Use On ACUSON S1000, S2000, S3000 Ultrasound
Device Name: Intended Use:
Systems Ultrasound imaging or fluid flow analysis of the human body as follows:
Intended Use:
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | ||||
Doppler | Amplitude | |||||||||
Doppler | Color | |||||||||
Velocity | ||||||||||
Imaging | Combined | |||||||||
(Specify) | Other | |||||||||
(Specify) | ||||||||||
Ophthalmic | ||||||||||
Fetal | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10 | ||
Abdominal | P | P | P | P | P | P | BMDC | Note 2 3 4 5 7 8 10 | ||
Intraoperative | ||||||||||
Pediatric | ||||||||||
Small Organ | ||||||||||
Neonatal Cephalic | ||||||||||
Adult Cephalic | ||||||||||
Cardiac | ||||||||||
Trans-esophageal | ||||||||||
Transrectal | ||||||||||
Transvaginal | P | P | P | P | P | P | BMDC | Note 2 3 4 5 6 7 8 | ||
10 | ||||||||||
Transurethral | ||||||||||
Intravascular | ||||||||||
Peripheral vessel | ||||||||||
Laparoscopic | ||||||||||
Musculo-skeletal | ||||||||||
Conventional | ||||||||||
Musculo-skeletal | ||||||||||
Superficial | ||||||||||
Other (specify) |
N = new indication: P = previously cleared by FDA \ # s 052410, 051139, 041319, 032114, 022567, 002807, 973767, 063085, K090334, K093812 , K111674. K121138
Additional Comments:
Ensemble tissue harmonic imaging Note 2
SieClear multi-view spatial compounding Note 3
Note 4 Tissue Equalization Technology
3-Scape real-time 3D imaging Note 5
Cadence contrast agent imaging Nole 6
B&W SieScape panoramic imaging Note 7
Power SieScape panoramic imaging Note 8
Note 10 Clarify VE vascular enhancement technology
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Health; Office of In Vitro Diagnostics and Radiological Health
510(k)_
Page 23 of _
S-Family 510(k) Submission
Page 40 of 64
32
S-Family Ultrasound Systems 510(k) Submission
Diagnostic Ultrasound Indications for Use Form
510 (k) Number (if known):
Device Name:
V7M TEE Transducer For Use On ACUSON S1000, S2000, S3000 Ultrasound Systems
Intended Use:
Ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | A | B | M | PWD | CWD | Color
Doppler | Power
(Amplitude)
Doppler | Color
Velocity
Imaging | Combined
(Specify) * | Harmonic
Imaging | Other
(Specify) |
|------------------------------------|---|---|---|-----|-----|------------------|---------------------------------|------------------------------|-------------------------|---------------------|--------------------|
| Ophthalmic | | | | | | | | | | | |
| Fetal | | | | | | | | | | | |
| Abdominal | | P | P | P | P | P | P | | P | P | Note 4 |
| Intraoperative | | | | | | | | | | | |
| Neurological | | | | | | | | | | | |
| Pediatric | | P | P | P | P | P | P | | P | P | Note 4 |
| Small Organ
(specify) ** | | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | | |
| Cardiac | | P | P | P | P | P | P | | P | P | Note 4 |
| Trans-esophageal | | P | P | P | P | P | P | | P | P | Note 4 |
| Transrectal | | | | | | | | | | | |
| Transvaginal | | | | | | | | | | | |
| Transurethral | | | | | | | | | | | |
| Intravascular | | | | | | | | | | | |
| Peripheral Vessel | | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | | |
| Musculo-skeletal
(Conventional) | | | | | | | | | | | |
| Musculo-skeletal
(Superficial) | | | | | | | | | | | |
| Other (specify) | | | | | | | | | | | |
P=previously cleared by the FDA under premarket notifications #K051139, #K041319, #K032114, and #K022567, K093812, K111674, K121138
Additional Comments:
*Combinations include: B+M, B+PWD, B+Color Doppler, B+M+ Color Doppler, B+PWD+Color Doppler, B+CWD+Color Doppler, B+Power Doppler, B+M+Power Doppler, B+PWD+Power Doppler, B+CWD+Power Doppler, B+Clarily VE
Ensemble tissue harmonic imaging Note 2
Note 4 Tissue Equalization Technology
Note 10 Clarify VE vascular enhancement technology
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OJR)
Division Sign-Off Division of Radiological Health; Office of in Viro Diagnostics and Radiological Health
510(k)_
Page 24 of ___________________________________________________________________________________________________________________________________________________________________
S-Family 510(k) Submission
Page 41 of 64
33
510 (k) Number (if known):
AcuNav 8F Ultrasound Catheter For Use On ACUSON S1000, S2000, S3000 Device Name: Ultrasound Systems Intended Use: Catheter is intended for intra-cardiac and intraluminal visualization of cardiac and great vessel anatomy and physiology as well as visualization of other devices in the heart of adult and pediatric patients.
| Clinical Application | A | B | M | PWD | CWD | Color
Doppler | Power
(Amplitude)
Doppler | Color
Velocity
Imaging | Combined
(Specify) * | Other:
Harmonic
Imaging |
|----------------------------------|---|---|---|-----|-----|------------------|---------------------------------|------------------------------|-------------------------|-------------------------------|
| Ophthalmic | | | | | | | | | | |
| Fetal | | | | | | | | | | |
| Abdominal | | | | | | | | | | |
| Intraoperative
(Vascular) | | | | | | | | | | |
| Intraoperative
(Neurological) | | | | | | | | | | |
| Pediatric | | P | P | P | P | P | P | | P | |
| Small Organ
(Specify) ** | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | |
| Cardiac | | P | P | P | P | P | P | | P | |
| Trans-esophageal | | | | | | | | | | |
| Transrectal | | | | | | | | | | |
| Transvaginal | | | | | | | | | | |
| Transurethral | | | | | | | | | | |
| Intra-Luminal | | P | P | P | P | P | P | | P | |
| Peripheral Vessel | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | |
| Musculo-skeletal
Conventional | | | | | | | | | | |
| Musculo-skeletal
Superficial | | | | | | | | | | |
| Other (Intra-Cardiac) | | P | P | P | P | P | P | | P | |
P=Previously cleared by the FDA K992631. K033650, K042593. K071234. K093812. K111674. K121138
Additional Comments:
*Combinations include B+M, B+PWD, B+CWD, B+Color Doppler, B+M+ Color Doppler, B+PW1)+Color Doppler, B+C'W1)+Color Doppler, B+Power Doppler,
B+M+POWER DOPPLER, B+PWD+POWER DOPPLER, B+CWD+POWER DOPPLER
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Health; Office of In Vitro Diagnostics and Radiological Health
510(k)_ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Page 25 പ ____________________________________________________________________________________________________________________________________________________________________
S-Family 510(k) Submission
Page 42 of 64
34
AcuNav 10F Ultrasound Catheter For Use On ACUSON S1000, S2000, S3000
510 (k) Number (if known):
Device Name:
Intended Use:
Ultrasound Systems Catheter is intended for intra-cardiac and intraluminal visualization of cardiac and great vessel anatomy and physiology as well as visualization of other devices in the heart of adult and pediatric patients.
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | ||||
Doppler | Power | |||||||||
(Amplitude) | ||||||||||
Doppler | Color | |||||||||
Velocity | ||||||||||
Imaging | Combined | |||||||||
(Specify) * | Other: | |||||||||
Harmonic | ||||||||||
Imaging | ||||||||||
Ophtalmic | ||||||||||
Fetal | ||||||||||
Abdominal | ||||||||||
Intraoperative | ||||||||||
(Vascular) | ||||||||||
Intraoperative | ||||||||||
(Neurological) | ||||||||||
Pediatric | P | P | P | P | P | P | P | |||
Small Organ | ||||||||||
(Specify)** | ||||||||||
Neonatal Cephalic | ||||||||||
Adult Cephalic | ||||||||||
Cardiac | P | P | P | P | P | P | P | |||
Trans-esophageal | ||||||||||
Transrectal | ||||||||||
Transvaginal | ||||||||||
Transurethral | ||||||||||
Intra-l.uminal | P | P | P | P | P | P | P | |||
Peripheral Vessel | ||||||||||
Laparoscopic | ||||||||||
Musculo-skeletal | ||||||||||
Conventional | ||||||||||
Musculo-skeletal | ||||||||||
Superficial | ||||||||||
Other (Intra-Cardiac) | P | P | P | P | P | P | P |
P=Previously cleared by the FDA K992631. K033650. K071234. K093812. K111674. K121138
Additional Comments:
*Combinations include: B+M, B+PWD, B+CWD, B+Color Doppler, B+M+ Color Doppler, Br.PWD+Color Doppler, B+CWD+Color Doppler, B+Power Doppler,
B+M+POWER DOPPLER, B+PWD+POWER DOPPLER, B+CWD+POWER DOPPLER
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Division Sign-Off Division of Radiological Health; Office of In Vitro Diagnosucs and Radiological Health
510(k)_
Page 25 of ___________________________________________________________________________________________________________________________________________________________________
S-Family 510(k) Submission
Page 43 of 64